BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16277203)

  • 1. [Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis].
    Katunina EA
    Eksp Klin Farmakol; 2005; 68(5):16-8. PubMed ID: 16277203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antioxidants in complex treatment of Parkinson's disease].
    Katunina EA; Malykhina EA; Kuznetsov NV; Avakian GN; Gusev Ei; nerobkova LN; Voronina TA; Barskov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):22-8. PubMed ID: 17069058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis].
    Golikov AP; Golikov PP; Davydov BV; Riabinin VA; Luk'ianov MM; Kalinin AN; Klychnikova EV; Promanenkov VK
    Kardiologiia; 2002; 42(3):25-9. PubMed ID: 12494182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Xerostomia. Diagnosis and treatment].
    Afanas'ev VV; Irmiiaev AA
    Stomatologiia (Mosk); 2004; 83(6):36-8. PubMed ID: 15602471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of mexidol on efficacy of traditional therapy of sick sinus syndrome in adolescents].
    Balykova LA
    Eksp Klin Farmakol; 2003; 66(5):25-7. PubMed ID: 14650210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mexidol in the complex treatment of patients in the acute period of tick borne encephalitis].
    Udintseva IN; Bartfel't NN; Zhukova NG; Poponina AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):34-8. PubMed ID: 23096037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of mexidol in patients with endocrine polyneuropathy].
    Kuznetsova EB; Sholomov II; Gerasimov SV; Salina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):97-9. PubMed ID: 24874328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of antioxidants on in vivo and in vitro methemoglobin formation in erytrocytes of patients with Parkinson`s disease].
    Makletsova MG; Rikhireva GT; Poleshuk VV; Grjakalov KV; Timerbaeva SL; Fedorova TN
    Biomed Khim; 2016; 62(2):193-7. PubMed ID: 27143379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant Mexidol premedication of patients with periodontitis during antihomotoxic therapy].
    Larentsova LI; Maksimovskiĭ IuM; Voronina TA; Grigorian KR
    Stomatologiia (Mosk); 2002; 81(2):20-2. PubMed ID: 12056134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of mexidol on the course of post-traumatic epilepsy].
    Novikov VE; Maslova NN
    Eksp Klin Farmakol; 2003; 66(4):9-11. PubMed ID: 14558343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of mexidol in pain syndromes].
    Danilova ED; Grafova VN; Voronina TA; Reshetniak VK
    Eksp Klin Farmakol; 1995; 58(3):17-20. PubMed ID: 7663286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of mexidol on the rat periodontium during hypokinesia].
    Kovalenko EG
    Fiziol Zh (1994); 1994; 40(3-4):87-93. PubMed ID: 7621961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
    Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
    Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex therapy of acute and exacerbated chronic nonspecific parotitis including mexidol and non-coherent infrared therapy].
    Deriabin EI; Shumikhina LA
    Stomatologiia (Mosk); 2006; 85(3):21-3. PubMed ID: 16858317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ; Zaharov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute radiation sickness in experiment. Efficacy of mexidol].
    Deshevoĭ IuB; Moroz BB; Cukoian GV; Voronina TA; Lebedev VG; Lyrshchikova AV
    Patol Fiziol Eksp Ter; 2007; (3):22-4. PubMed ID: 17933047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of mexidol in psychiatric practice].
    Kosenko VG; Karagezian EA; Luneva LV; Smolenko LF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):38-41. PubMed ID: 16841482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypoxic and antinecrotic effect of mexidol in skin ischemia.
    Galenko-Yaroshevskii VP; Bagmetova EN; Fil'chukova IA; Sidel'nikov AY; Popkov VA; Gorelashvili AS; Antelava NA; Sukoyan GV
    Bull Exp Biol Med; 2005 Feb; 139(2):202-6. PubMed ID: 16027807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.